Cargando…

Examining the freezing process of an intermediate bulk containing an industrially relevant protein

Numerous biopharmaceuticals are produced in recombinant microorganisms in the controlled environment of a bioreactor, a process known as Upstream Process. To minimize product loss due to physico-chemical and enzymatic degradation, the Upstream Process should be directly followed by product purificat...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinsch, Holger, Spadiut, Oliver, Heidingsfelder, Johannes, Herwig, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370381/
https://www.ncbi.nlm.nih.gov/pubmed/25765305
http://dx.doi.org/10.1016/j.enzmictec.2015.01.003
_version_ 1782362862005518336
author Reinsch, Holger
Spadiut, Oliver
Heidingsfelder, Johannes
Herwig, Christoph
author_facet Reinsch, Holger
Spadiut, Oliver
Heidingsfelder, Johannes
Herwig, Christoph
author_sort Reinsch, Holger
collection PubMed
description Numerous biopharmaceuticals are produced in recombinant microorganisms in the controlled environment of a bioreactor, a process known as Upstream Process. To minimize product loss due to physico-chemical and enzymatic degradation, the Upstream Process should be directly followed by product purification, known as Downstream Process. However, the Downstream Process can be technologically complex and time-consuming which is why Upstream and Downstream Process usually have to be decoupled temporally and spatially. Consequently, the product obtained after the Upstream Process, known as intermediate bulk, has to be stored. In those circumstances, a freezing procedure is often performed to prevent product loss. However, the freezing process itself is inseparably linked to physico-chemical changes of the intermediate bulk which may in turn damage the product. The present study analysed the behaviour of a Tris-buffered intermediate bulk containing a biopharmaceutically relevant protein during a bottle freezing process. Major damaging mechanisms, like the spatiotemporal redistribution of ion concentrations and pH, and their influence on product stability were investigated. Summarizing, we show the complex events which happen in an intermediate bulk during freezing and explain the different causes for product loss.
format Online
Article
Text
id pubmed-4370381
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-43703812015-04-01 Examining the freezing process of an intermediate bulk containing an industrially relevant protein Reinsch, Holger Spadiut, Oliver Heidingsfelder, Johannes Herwig, Christoph Enzyme Microb Technol Article Numerous biopharmaceuticals are produced in recombinant microorganisms in the controlled environment of a bioreactor, a process known as Upstream Process. To minimize product loss due to physico-chemical and enzymatic degradation, the Upstream Process should be directly followed by product purification, known as Downstream Process. However, the Downstream Process can be technologically complex and time-consuming which is why Upstream and Downstream Process usually have to be decoupled temporally and spatially. Consequently, the product obtained after the Upstream Process, known as intermediate bulk, has to be stored. In those circumstances, a freezing procedure is often performed to prevent product loss. However, the freezing process itself is inseparably linked to physico-chemical changes of the intermediate bulk which may in turn damage the product. The present study analysed the behaviour of a Tris-buffered intermediate bulk containing a biopharmaceutically relevant protein during a bottle freezing process. Major damaging mechanisms, like the spatiotemporal redistribution of ion concentrations and pH, and their influence on product stability were investigated. Summarizing, we show the complex events which happen in an intermediate bulk during freezing and explain the different causes for product loss. Elsevier 2015-04 /pmc/articles/PMC4370381/ /pubmed/25765305 http://dx.doi.org/10.1016/j.enzmictec.2015.01.003 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Reinsch, Holger
Spadiut, Oliver
Heidingsfelder, Johannes
Herwig, Christoph
Examining the freezing process of an intermediate bulk containing an industrially relevant protein
title Examining the freezing process of an intermediate bulk containing an industrially relevant protein
title_full Examining the freezing process of an intermediate bulk containing an industrially relevant protein
title_fullStr Examining the freezing process of an intermediate bulk containing an industrially relevant protein
title_full_unstemmed Examining the freezing process of an intermediate bulk containing an industrially relevant protein
title_short Examining the freezing process of an intermediate bulk containing an industrially relevant protein
title_sort examining the freezing process of an intermediate bulk containing an industrially relevant protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370381/
https://www.ncbi.nlm.nih.gov/pubmed/25765305
http://dx.doi.org/10.1016/j.enzmictec.2015.01.003
work_keys_str_mv AT reinschholger examiningthefreezingprocessofanintermediatebulkcontaininganindustriallyrelevantprotein
AT spadiutoliver examiningthefreezingprocessofanintermediatebulkcontaininganindustriallyrelevantprotein
AT heidingsfelderjohannes examiningthefreezingprocessofanintermediatebulkcontaininganindustriallyrelevantprotein
AT herwigchristoph examiningthefreezingprocessofanintermediatebulkcontaininganindustriallyrelevantprotein